Abilify (otherwise known as aripiprazole) was approved by the U.S. Food and Drug Administration for schizophrenia on November 15, 2002. It got approval by the European Medicines Agency on 4 June 2004. It goes off-patent in October 2014. Until then, there is no generic formulation.
![]() |
Source: Drugs.com. |
Why is an atypical antipsychotic drug suddenly selling so well in the U.S.? Several reasons.
Abilify is widely prescribed as an adjunctive (or supplemental) medication for depression. Korea Otsuka Pharmaceutical Co., Ltd., which markets Abilify jointly with Bristol-Myers Squibb (BMS), received FDA approval for the drug's use as an adjunct for major depressive disorder on November 20, 2007; and to treat irritability in children with autism on 20 November 2009.
But that's not the whole story. Abilify is also widely prescribed off-label, to treat a variety of conditions in children, plus dementia (Alzheimer's disease) in the elderly. While it's not illegal for doctors to prescribe drugs in an off-label way, the off-label use of antipsychotic drugs (for children, especially) is ill-advised, given the potential for adverse side effects and the lack of efficacy data for such uses. It should be noted that Bristol-Myers Squibb was fined $515 million in September 2007 for recommending off-label uses of Abilify (among other charges).
One thing is certain: Abilify didn't make it to the top of the charts by virtue of its efficacy (which, as an adjunct to antidepressants, is only slightly better than placebo). It made it there, in part, by a massive advertising campaign in the U.S. that urged Americans to their doctor and "ask if Abilify is right for you."
It also made it to the best-seller list by a variety of flat-out underhanded marketing practices. Bristol-Myers Squibb's 2007 settlement agreement with the U.S. Government was based on the Justice Department's contention that:
BMS knowingly and willfully paid illegal remuneration to physicians and other health care providers to induce them to purchase BMS drugs. BMS paid the illegal remuneration in the form of consulting fees and expenses to physicians and other health care providers to participate in various consulting programs, advisory boards, and preceptorships. Some of these programs involved travel to luxurious resorts. The Government also alleged that, from 1994 through 2001, Apothecon [a BMS wholly owned subsidiary] knowingly and willfully paid illegal remuneration such as stocking allowances, price protection payments, prebates, market share payments, and free goods in order to induce its retail pharmacy and wholesaler customers to purchase its products. [from press release]It's a simple formula for success, really. Come up with a drug that works no better than older medications, for a condition (schizophrenia) that only 1 in 100 people have; announce that it's a wonder drug; pay doctors to prescribe it; encourage physicians to find untested uses for it; pay "stocking allowances" to drug stores; tell consumers who almost certainly don't need it to ask their doctor for it; and meanwhile set its price so high that it's 100 to 200 times more valuable, ounce for ounce, than pure gold.
What could possibly go wrong?
Why aren't people concerned that an ANTI-PSYCHOTIC is the number one drug in America? What does that say about us? P.S. Did you know that the U.S. and New Zealand are the only two countries that allow direct-to-consumer advertisement by pharmaceutical companies. Now we know who buys our regulators and legislators. Sad commentary for us.
ReplyDeleteThe side effects of Abilify make me feel ill. Stop using it has made me feel much better. How terrible it is the advertisement affects our lives.
ReplyDelete"""MedCepts is THE Largest Network of Independent Consultants, Independent Contractors, Independent Sales Reps, Independent Distributors and Independent Healthcare providers, exclusive to the medical and healthcare industry.
ReplyDeleteThe network includes a diversified network of individuals, companies and niche specialty consultants with experience from the “New Idea to Concept” & Distribution. Companies range from start-ups, incubating organizations to Multi-national Fortune 500.
The focus of our network is to provide support for sourcing & outsourcing processes of the healthcare industry and thus to facilitate the search for suitable contractors for specific services. Niche specialists and consultants for all life cycles for medical / healthcare related devices, products and services. Visit the network at www.medcepts.com """
An interesting dialogue is price comment. I feel that it is best to write more on this matter,
ReplyDeletechance to pass drug test
this blog is more information are provide.
ReplyDeleteto get online pharmacy from does pharmacy.
نقل عفش بابها
ReplyDeleteنقل عفش برابغ
شركات نقل العفش بجازان
نقل عفش بجازان
دينا نقل عفش داخل وخارج مكة
دينا نقل عفش داخل وخارج الرياض
شركات نقل العفش بخميس مشيط
افضل شركة نقل عفش بحائل
ReplyDeleteشركة المتحدة
دليل شركات نقل العفش
شركة نقل اثاث بالمدينة المنورة
شركة نقل اثاث بالرياض
شركة نقل اثاث بجدة
شركة نقل اثاث بمكة
شركة نقل اثاث بالطائف
شركة نقل اثاث بينبع
ReplyDeleteشركة ريلاكس لنقل العفش والاثاث
شركة نقل عفش بالطائف
شركة نقل عفش بالرياض
شركة نقل عفش بجدة
شركة نقل عفش بمكة
شركة نقل عفش بالمدينة المنورة
شركة نقل عفش بخميس مشيط